Jade Biosciences, Inc. (JBIO)
Jade Biosciences, Inc. (JBIO) has reported earnings 17 times since Aug 16, 2021. The stock moves an average of ±5.00% the day after reporting, closing higher 52.9% of the time. Its largest post-earnings gain was +10.54% (Nov 14, 2025) and its largest decline was -18.94% (Nov 15, 2021). The next earnings report is predicted for 2026-08-13 (approximate).
Earnings reactions
How JBIO moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±5.00%
Positive %
52.9%
Negative %
47.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☽ POST | +6.36% | open_in_new |
| Mar 06, 2026 | ☀ PRE | +1.22% | open_in_new |
| Nov 14, 2025 | ☀ PRE | +10.54% | open_in_new |
| Aug 13, 2025 | ☽ POST | -7.64% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±5.00%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260717 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260708 | open_in_new SEC.gov |
| 8-K | 20260701 | open_in_new SEC.gov |
| 3 | 20260626 | open_in_new SEC.gov |
| 4 | 20260626 | open_in_new SEC.gov |
| 8-K | 20260626 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
| 4 | 20260611 | open_in_new SEC.gov |
Frequently asked about JBIO earnings
When does Jade Biosciences, Inc. report earnings next? expand_more
Jade Biosciences, Inc. (JBIO)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does JBIO stock move after earnings? expand_more
Over 17 reports, JBIO has moved an average of ±5.00% the session after earnings, closing higher 52.9% of the time.
What was JBIO's biggest post-earnings move? expand_more
JBIO's largest post-earnings gain on record was +10.54% on Nov 14, 2025, and its largest decline was -18.94% on Nov 15, 2021.
Where can I find Jade Biosciences, Inc.'s SEC filings? expand_more
All of Jade Biosciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right